Cart summary

You have no items in your shopping cart.

Phospho-MAPKAPK2 (Thr334) Antibody

Phospho-MAPKAPK2 (Thr334) Antibody

Catalog Number: orb572310

Select Product Size
SizePriceQuantity
100 μl$ 400.00
100 μl Enquire
DispatchUsually dispatched within 5-10 working days
Product Properties
Catalog Numberorb572310
CategoryAntibodies
DescriptionThis Phospho-MAPKAPK2 (Thr334) Antibody is an unconjugated polyclonal product. It tagets MAPKAPK2 using a Peptide sequence around phosphorylation site of threonine 334 (P-Q-T(p)-P-L) derived from Human MAPKAPK-2 as the immunogen. This antibody is suitable for ELISA, IF, IHC, WB.
TargetMAPKAPK2
ClonalityPolyclonal
Species/HostRabbit
IsotypeIgG
ConjugationUnconjugated
ReactivityHuman, Mouse, Rat
Form/Appearanceliquid
Buffer/PreservativesSupplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
PurificationAntibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
ImmunogenPeptide sequence around phosphorylation site of threonine 334 (P-Q-T(p)-P-L) derived from Human MAPKAPK-2.
UniProt IDP49137
Tested applicationsELISA, IF, IHC, WB
Dilution rangeWB: 1:500-1:1000, IHC-P: 1:50-1:100, IF: 1:100-1:200
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Alternative namesMAP kinase activated protein Kinase 2 antibody; MA
Read more...
Research AreaCardiovascular Research
NoteFor research use only
Images
Similar Products
Reviews

Phospho-MAPKAPK2 (Thr334) Antibody (orb572310)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet